CS logo
small CS logo
Medical Associates of North Georgia

Canton, Georgia, United States
Medical clinic in Canton, Georgia
320 Hospital Rd, Canton, GA 30114

About Medical Associates of North Georgia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Medical Associates of North Georgia


During the past decade, Medical Associates of North Georgia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0820, Adenoma and Second Primary Prevention Trial
2013-03-01
2032-02-01
Recruiting
1,340
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452

Rows per page:

1–44 of 44

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Medical Associates of North Georgia" #1 sponsor was "Chelsea Therapeutics" with 2 trials, followed by "Alexion" with 1 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Associates of North Georgia" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Medical Associates of North Georgia


According to Clinical.Site data, the most researched conditions in "Medical Associates of North Georgia" are "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Rheumatoid Arthritis" (2 trials), "Alzheimer's Disease" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Medical Associates of North Georgia" in a lesser frequency.

Clinical Trials Intervention Types at Medical Associates of North Georgia


Most popular intervention types in "Medical Associates of North Georgia" are "Drug" (7 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Droxidopa" (2 trials), "Eculizumab" (1 trials), "Filgotinib" (1 trials) and "Filgotinib placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Medical Associates of North Georgia


The vast majority of trials in "Medical Associates of North Georgia" are 8 trials for "All" genders.

Clinical Trials Status at Medical Associates of North Georgia


Currently, there are NaN active trials in "Medical Associates of North Georgia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Medical Associates of North Georgia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medical Associates of North Georgia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status